Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is N/A as of Tuesday, October 6, 2026.
OPERATING MARGIN
N/A
Veraxa Biotech Holding AG
Market Cap
$152.72M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$153.58M
Operating Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$153.79M
Operating Margin
-14.74%
TTM Avg
-33.61%
3Y Avg
-40.97%
5Y Avg
-43.17%
Market Cap
$151.01M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-8182.07%
Market Cap
$149.36M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-615.66%
Market Cap
$156.22M
Operating Margin
-8.45%
TTM Avg
-10.66%
3Y Avg
-19.64%
5Y Avg
-13.31%
Market Cap
$148.73M
Operating Margin
-239.78%
TTM Avg
-210.59%
3Y Avg
-1665.90%
5Y Avg
-1977.59%
Market Cap
$148.64M
Operating Margin
-326.56%
TTM Avg
-215.34%
3Y Avg
-126.53%
5Y Avg
-114.48%
Market Cap
$148.27M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Veraxa Biotech Holding AG (VRXA) | $152.72M | N/A | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $153.58M | N/A | 0.00% | 0.00% | 0.00% |
| Neuronetics, Inc. (STIM)vs › | $153.79M | -14.74% | -33.61% | -40.97% | -43.17% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | 0.00% | 0.00% | 0.00% | -8182.07% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | 0.00% | 0.00% | 0.00% | -615.66% |
| Inogen, Inc. (INGN)vs › | $156.22M | -8.45% | -10.66% | -19.64% | -13.31% |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | -239.78% | -210.59% | -1665.90% | -1977.59% |
| Voyager Therapeutics, Inc. (VYGR)vs › | $148.64M | -326.56% | -215.34% | -126.53% | -114.48% |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | 0.00% | 0.00% | 0.00% | -91.83% |
Gross Margin
N/A
Operating Margin
N/A
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
